Lilan Yi
Impact in
-
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 4
- Co-authors
- Guowu Wu (6 shared papers)Xiaofang Zou (7 shared papers)Longhua Guo (6 shared papers)Ping Huang (2 shared papers)Jian Zhang (7 shared papers)Peng Luo (7 shared papers)Junsheng Fan (1 shared paper)Hongman Zhang (4 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Journal of Cancer (2 papers)Pharmacological Research (1 paper)Frontiers in Pediatrics (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- China
In The Last Decade
Lilan Yi
13 papers receiving 365 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 123
- Oncology 129
- Pulmonary and Respiratory Medicine 136
- Molecular Biology 202
- Obstetrics and Gynecology 16
Countries citing papers authored by Lilan Yi
This map shows the geographic impact of Lilan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilan Yi more than expected).
Fields of papers citing papers by Lilan Yi
This network shows the impact of papers produced by Lilan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilan Yi. The network helps show where Lilan Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilan Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 154 | |
| 2 | 2019 | 54 | |
| 3 | 2020 | 36 | |
| 4 | 2019 | 34 | |
| 5 | 2021 | 22 | |
| 6 | 2018 | 17 | |
| 7 | 2018 | 13 | |
| 8 | 2020 | 13 | |
| 9 | 2018 | 9 | |
| 10 | 2020 | 7 | |
| 11 | 2022 | 5 | |
| 12 | 2019 | 5 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 0 | |
| 15 | 2024 | 0 | |
| 16 | 2021 | 0 |
About Lilan Yi
Lilan Yi is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Organic Chemistry, having authored 16 papers that have together received 371 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Lung Cancer Research Studies (4 papers), RNA modifications and cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Inflammatory mediators and NSAID effects (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Synthesis of β-Lactam Compounds (2 papers). The work is most often cited by research in Cancer Research (123 citations), Oncology (129 citations), Pulmonary and Respiratory Medicine (136 citations), Molecular Biology (202 citations) and Obstetrics and Gynecology (16 citations). Lilan Yi has collaborated with scholars based in China. Frequent co-authors include Guowu Wu, Xiaofang Zou, Longhua Guo, Ping Huang, Jian Zhang, Peng Luo, Junsheng Fan, Hongman Zhang, Ping Huang and Jingwen Zou. Their work appears in journals such as Frontiers in Oncology, Journal of Cancer, Pharmacological Research, Frontiers in Pediatrics and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.